TrialThe Lancet. Neurology2020

Efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis (MS-SMART): a phase 2b, multiarm, double-blind, randomised placebo-controlled trial.

Jeremy Chataway et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.